Solesence, Inc. Common Stock (SLSN)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ
Market Cap: $107.38M
Last updated: Nov 17, 2026 at 11:05 AM ET
Solesence, Inc. Common Stock (SLSN) P/E Ratio & Valuation History
Solesence, Inc. Common Stock (SLSN) trades at 19.7x trailing earnings and 1.9x sales. Its P/B of 6.7x is below its 5-year median of 12.5x. Its forward P/E is 11.4x. The median P/E across 5 similar companies is 11.1x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 72.8% higher over the next year. Its free cash flow yield is 7.3%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 19.7x |
| Forward P/E | 11.4x |
| Price to sales | 1.9x |
| Price to book | 6.7x |
| EV/EBITDA | 23.2x |
| Price to FCF | 13.7x |
| EV/FCF | 14.6x |
| PEG | N/A |
| FCF yield | 7.3% |
Historical Medians
Against its 10-year medians, its P/B is 38.5% below 10.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 6.7x | 12.5x | 10.9x |
Valuation History
Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 32.9x in 2020 to 66.9x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $1.60 | 58.2x | 1.8x | 6.6x |
| 2024 | $2.44 | 39.2x | 2.9x | 11.4x |
| 2023 | $0.60 | N/A | 0.8x | 15.7x |
| 2022 | $1.13 | N/A | N/A | 7.5x |
| 2021 | $4.40 | 66.9x | N/A | 27.6x |
| 2020 | $0.85 | 32.9x | N/A | 13.1x |
| 2019 | $0.28 | N/A | N/A | 8.7x |
| 2018 | $0.73 | N/A | N/A | 10.2x |
| 2017 | $0.52 | N/A | N/A | 6.9x |
| 2016 | $0.72 | N/A | N/A | 6.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SLSN
What is SLSN's forward P/E ratio?
Solesence, Inc. Common Stock has a forward P/E ratio of 11.4x.
Is SLSN stock overvalued?
GNG's valuation label for SLSN is Undervalued. Its P/E of 19.7x compares with a median of 11.1x across 5 similar companies.
What is SLSN's price to sales ratio?
Solesence, Inc. Common Stock has a price to sales ratio of 1.9x.
SLSN pages: Overview, Earnings, Financials, Valuation, Competitors